Journal of the American Society of Hypertension
Volume 4, Issue 5 , Pages 244-254 , September 2010

Level of blood pressure above goal and clinical inertia in a Medicaid population

  • Anthony J. Viera, MD, MPH

      Affiliations

    • Department of Family Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
    • Corresponding Author InformationCorresponding author: Anthony J. Viera, MD, MPH, Assistant Professor, Department of Family Medicine, University of North Carolina at Chapel Hill, 590 Manning Drive, CB 7595, Chapel Hill, NC 27599. Tel: 919–966–0758.
  • ,
  • Dorothee Schmid, MA

      Affiliations

    • North Carolina State Center for Health Statistics, Raleigh, North Carolina, USA
  • ,
  • Susan Bostrom, RN

      Affiliations

    • North Carolina Division of Medical Assistance, Raleigh, North Carolina, USA
  • ,
  • Angie Yow, RN

      Affiliations

    • North Carolina Division of Medical Assistance, Raleigh, North Carolina, USA
  • ,
  • William Lawrence, MD

      Affiliations

    • North Carolina Division of Medical Assistance, Raleigh, North Carolina, USA
    • Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
    • Duke Primary Care, Duke University Health Systems, Durham, North Carolina, USA
  • ,
  • C. Annette DuBard, MD, MPH

      Affiliations

    • Department of Family Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
    • North Carolina Division of Medical Assistance, Raleigh, North Carolina, USA
    • Cecil G. Sheps Center for Health Services Research, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA

Received 24 May 2010 ,Accepted 22 July 2010.

References 

  1. Gu Q, Burt VL, Paulose-Ram R, Yoon S, Gillum RF. High blood pressure and cardiovascular disease mortality risk among US adults: the Third National Health and Nutrition Examination Survey Mortality Follow-up Study. Ann Epidemiol. 2008;18:302–309
  2. Berlowitz DR, Ash AS, Hickey EC, Friedman RH, Glickman M, Kader B, et al. Inadequate management of blood pressure in a hypertensive population. N Engl J Med. 1998;339:1957–1963
  3. Hyman DJ, Pavlik VN. Poor hypertension control: let’s stop blaming the patients. Cleve Clin J Med. 2002;69:793–799
  4. Hyman DJ, Pavlik VN. Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med. 2001;345:479–486
  5. Phillips LS, Branch WT, Cook CB. Clinical inertia. Ann Intern Med. 2001;135:825–834
  6. Kerr EA, Zikmund-Fisher BJ, Klamerus ML, Subramanian U, Hogan MM, Hofer TP. The role of clinical uncertainty in treatment decisions for diabetic patients with uncontrolled blood pressure. Ann Intern Med. 2008;148:717–727
  7. Ferrari P, Hess L, Pechere-Bertschi A, Muggli F, Burnier M. Reasons for not intensifying antihypertensive treatment (RIAT): a primary care antihypertensive intervention study. J Hypertens. 2004;22:1221–1229
  8. MacDonald MB, Laing GP, Wilson MP, Wilson TW. Prevalence and predictors of white-coat response in patients with treated hypertension. CMAJ. 1999;161:265–269
  9. Myers MG, Oh PI, Reeves RA, Joyner CD. Prevalence of white coat effect in treated hypertensive patients in the community. Am J Hypertens. 1995;8:591–597
  10. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560–2572
  11. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality, 2002 Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903–1913
  12. Turner BJ, Hollenbeak CS, Weiner M, Ten Have T, Tang SS. Effect of unrelated comorbid conditions on hypertension management. Ann Intern Med. 2008;148:578–586
  13. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998;317:703–713
  14. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288:2981–2997
  15. Beckett NS, Peters R, Fletcher AE, Staessen JA, Liu L, Dumitrascu D, et al. HYVET Study Group Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008;358:1887–1898
  16. Fagard RH, Staessen JA, Thijs L, Celis H, Bulpitt CJ, de Leeuw PW, et al. On-treatment diastolic blood pressure and prognosis in systolic hypertension. Arch Intern Med. 2007;167:1884–1891
  17. Patel A ADVANCE Collaborative Group, MacMahon S, Chalmers J, Neal B, Woodward M, et al. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomized controlled trial. Lancet. 2007;370:829–840
  18. Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S, et al. for the HOT Study Group Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. Lancet. 1998;351:1755–1762
  19. Schrier RW, Estacio RO, Esler A, Mehler P. Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes. Kidney Int. 2002;61:1086–1097
  20. Mensah GA, Mokdad AH, Ford ES, Greenlund KJ, Croft JB. State of disparities in cardiovascular health in the United States. Circulation. 2005;111:1233–1241
  21. Alexander M, Tekawa I, Hunkeler E, Fireman B, Rowell R, Selby JV, et al. Evaluating hypertension control in a managed care setting. Arch Intern Med. 1999;159:2673–2677
  22. National Committee for Quality Assurance (NCQA) Web site. Available at: http://www.ncqa.org/tabid/59/Default.aspx. Accessed December 7, 2009.
  23. The State of Health Care Quality 2009. National Committee for Quality Assurance, Washington, DC. Available at: http://www.ncqa.org/Portals/0/Newsroom/SOHC/SOHC_2009.pdf. Accessed December 31, 2009.
  24. Østbye T, Yarnall KS, Krause KM, Pollak KI, Gradison M, Michener JL. Is there time for management of patients with chronic diseases in primary care?. Ann Fam Med. 2005;3:209–214
  25. Green BB, Cook AJ, Ralston JD, Fishman PA, Catz SL, Carlson J, et al. Effectiveness of home blood pressure monitoring, web communication, and pharmacist care on hypertension control: a randomized controlled trial. JAMA. 2008;299:2857–2867
  26. Walsh JM, McDonald KM, Shojania KG, Sundaram V, Nayak S, Lewis R, et al. Quality improvement strategies for hypertension management: a systematic review. Med Care. 2006;44:646–657

 Funding/support: Dr. Viera’s time to develop this article was supported by a career development award from the National Institutes of Health (KL2RR025746).

 Conflict of interest: none.

PII: S1933-1711(10)00160-9

doi: 10.1016/j.jash.2010.07.003

Journal of the American Society of Hypertension
Volume 4, Issue 5 , Pages 244-254 , September 2010